Publikationen (35) Publikationen von Ainara Vallejo Illarramendi

2024

  1. Development of an in vitro platform for the analysis of contractile and calcium dynamics in single human myotubes

    Lab on a Chip, Vol. 24, Núm. 20, pp. 4741-4754

  2. Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosis

    Acta Neuropathologica, Vol. 148, Núm. 1

  3. Immortalized human myotonic dystrophy type 1 muscle cell lines to address patient heterogeneity

    iScience, Vol. 27, Núm. 6

2023

  1. Loss of the matrix metalloproteinase-10 causes premature features of aging in satellite cells

    Frontiers in Cell and Developmental Biology, Vol. 11

  2. Pharmacokinetic Evaluation of New Drugs Using a Multi-Labelling Approach and PET Imaging: Application to a Drug Candidate with Potential Application in Neuromuscular Disorders

    Biomedicines, Vol. 11, Núm. 2

2022

  1. A Ca2+-Dependent Mechanism Boosting Glycolysis and OXPHOS by Activating Aralar-Malate-Aspartate Shuttle, upon Neuronal Stimulation

    The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 42, Núm. 19, pp. 3879-3895

  2. Contractile force assessment methods for in vitro skeletal muscle tissues

    eLife, Vol. 11

  3. Electroactive 3D printable poly(3,4-ethylenedioxythiophene)-: Graft -poly(ϵ-caprolactone) copolymers as scaffolds for muscle cell alignment

    Polymer Chemistry, Vol. 13, Núm. 1, pp. 109-120

  4. Targeting the Ubiquitin-Proteasome System in Limb-Girdle Muscular Dystrophy With CAPN3 Mutations

    Frontiers in Cell and Developmental Biology, Vol. 10

2021

  1. 3D Printable Conducting and Biocompatible PEDOT-graft-PLA Copolymers by Direct Ink Writing

    Macromolecular Rapid Communications, Vol. 42, Núm. 12

  2. Discovery of a novel family of FKBP12 “reshapers” and their use as calcium modulators in skeletal muscle under nitro-oxidative stress

    European Journal of Medicinal Chemistry, Vol. 213

  3. Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies

    Neuropathology and Applied Neurobiology, Vol. 47, Núm. 6, pp. 711-723

2020

  1. A genotyping method combining primer competition PCR with HRM analysis to identify point mutations in Duchenne animal models

    Scientific Reports, Vol. 10, Núm. 1

  2. In vitro human skeletal muscle platform for the evaluation of functional outcomes

    XXXVIII Congreso Anual de la Sociedad Española de Ingeniería Biomédica. CASEIB 2020: Libro de actas

2019

  1. COST Actions: fostering collaborative research for rare diseases

    The Lancet Neurology

  2. Calcium Mechanisms in Limb-Girdle Muscular Dystrophy with CAPN3 Mutations

    International Journal of Molecular Sciences, Vol. 20, Núm. 18

2017

  1. Insights into the mechanisms of copper dyshomeostasis in amyotrophic lateral sclerosis

    Expert Reviews in Molecular Medicine, Vol. 19

2016

  1. Calpain 3 deficiency affects SERCA expression and function in the skeletal muscle

    Expert Reviews in Molecular Medicine, Vol. 18

  2. Increased aquaporin 1 and 5 membrane expression in the lens epithelium of cataract patients

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1862, Núm. 10, pp. 2015-2021

2014

  1. Dysregulation of calcium homeostasis in muscular dystrophies

    Expert reviews in molecular medicine, Vol. 16, pp. e16